583 related articles for article (PubMed ID: 23987516)
41. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
[TBL] [Abstract][Full Text] [Related]
42. Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience.
Nurudeen SK; Douglas NC; Mahany EL; Sauer MV; Choi JM
Am J Clin Oncol; 2016 Apr; 39(2):154-9. PubMed ID: 24441581
[TBL] [Abstract][Full Text] [Related]
43. Ovarian stimulation for fertility preservation in patients with cancer.
Quintero RB; Helmer A; Huang JQ; Westphal LM
Fertil Steril; 2010 Feb; 93(3):865-8. PubMed ID: 19013563
[TBL] [Abstract][Full Text] [Related]
44. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
45. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
[TBL] [Abstract][Full Text] [Related]
46. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
47. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
48. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
49. Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.
Wald K; Cakmak H; Mok-Lin E; Cedars M; Rosen M; Letourneau J
J Assist Reprod Genet; 2019 Jun; 36(6):1161-1168. PubMed ID: 31127475
[TBL] [Abstract][Full Text] [Related]
50. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
[TBL] [Abstract][Full Text] [Related]
51. Luteal phase stimulation, the future of fertility preservation? Retrospective cohort study of luteal phase versus follicular phase stimulation.
Jochum F; Sananès N; Teletin M; Lichtblau I; Rongières C; Pirrello O
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):91-94. PubMed ID: 30439518
[TBL] [Abstract][Full Text] [Related]
52. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
[TBL] [Abstract][Full Text] [Related]
53. Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations.
von Wolff M; Capp E; Jauckus J; Strowitzki T; Germeyer A;
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():146-9. PubMed ID: 26927896
[TBL] [Abstract][Full Text] [Related]
54. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients.
Demirtas E; Elizur SE; Holzer H; Gidoni Y; Son WY; Chian RC; Tan SL
Reprod Biomed Online; 2008 Oct; 17(4):520-3. PubMed ID: 18854106
[TBL] [Abstract][Full Text] [Related]
55. Follicular steroidogenesis in random start protocols for oocyte cryopreservation.
Galati G; Somigliana E; Ciaffaglione M; Reschini M; Serra N; Sanzani E; Viganò P; Polledri E; Fustinoni S; Muzii L; Filippi F
J Assist Reprod Genet; 2023 Sep; 40(9):2149-2156. PubMed ID: 37439869
[TBL] [Abstract][Full Text] [Related]
56. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients.
Tsampras N; Roberts SA; Gould D; Fitzgerald CT
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12797. PubMed ID: 29168588
[TBL] [Abstract][Full Text] [Related]
57. Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.
Pereira N; Hubschmann AG; Lekovich JP; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Aug; 108(2):357-360. PubMed ID: 28629583
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of ovarian stimulation in the follicular and luteal phases of the menstrual cycle in cancer patients.
Nazarenko TA; Martirosyan YO; Birukova AM; Korneeva IE; Sokolova J; Khubaeva DG
Gynecol Endocrinol; 2021; 37(sup1):13-16. PubMed ID: 34937510
[TBL] [Abstract][Full Text] [Related]
59. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
60. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation.
Nayak SR; Wakim AN
Fertil Steril; 2011 Jul; 96(1):e51-4. PubMed ID: 21601193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
